45 results
6-K
CNTB
Connect Biopharma Holdings Ltd
12 Sep 23
Connect Biopharma Reports First Half 2023 Financial Results and Provides Business Update
4:47pm
totaling RMB 3.7 million (USD 0.5 million) and a research and development tax incentive from the Australia government totaling RMB 6.3 million (USD 0.9 … Compensation
2019 Stock Incentive Plan
The Group adopted the 2019 Stock Incentive Plan (“2019 Plan”) and obtained Board’s approval on November 1, 2019, under
6-K
hjd ywi93
13 Sep 22
Connect Biopharma Reports First Half 2022 Financial Results
4:47pm
S-8
EX-5.1
pz1w0ols mtxz
1 Jul 22
Registration of securities for employees
5:12pm
S-8
ezssfvtbye
1 Jul 22
Registration of securities for employees
5:12pm
S-8
eq9 u1jzl28nbzqwls
1 Jul 22
Registration of securities for employees
5:12pm
F-3/A
f0ny7p6 oa4vve6ktfyt
17 Jun 22
Shelf registration (foreign) (amended)
5:19pm
F-3/A
b3p8i
20 May 22
Shelf registration (foreign) (amended)
6:54pm
F-3
vi7 84eyc7
15 Apr 22
Shelf registration (foreign)
5:27pm
F-3
EX-1.2
x8t9x80
15 Apr 22
Shelf registration (foreign)
5:27pm
20-F
EX-4.10
utrzlz5o98p95ix aj
31 Mar 22
Annual report (foreign)
4:33pm
20-F
EX-4.11
xf9c6m8gqg2od4p xm9j
31 Mar 22
Annual report (foreign)
4:33pm
20-F
EX-1.1
8fdsogzvpqik
31 Mar 22
Annual report (foreign)
4:33pm
20-F
lbuh9fi9
31 Mar 22
Annual report (foreign)
4:33pm
20-F
EX-4.5
9syq0c437y5jmw 9xd
31 Mar 22
Annual report (foreign)
4:33pm
6-K
EX-99.1
qnqi860
31 Aug 21
Index to the Unaudited Interim Condensed Consolidated Financial Statements
4:16pm
6-K
EX-99.2
3i9d3lc0v 7p
31 Aug 21
Index to the Unaudited Interim Condensed Consolidated Financial Statements
4:16pm